KPV 15 mg peptide pen
The three-residue tail of alpha-MSH, studied for inflammation, fifteen milligrams of the quietest interesting compound in the catalogue.
- ISO-certified laboratory
- COA per batch, ≥99% HPLC
- Discreet dispatch within 24 h
- Research use only
Three residues, one focused question
KPV, Lys-Pro-Val, is the C-terminal fragment of alpha-MSH that carries its anti-inflammatory signal without the pigmentation activity of the parent hormone. That separation of functions is the research story: inflammation modulation from a sequence three residues long.
The literature runs through gut and skin inflammation models with a consistency that keeps the compound in research catalogues despite its low profile; the KPV entries on PubMed are where that consistency is visible. The pen serves the systemic route; the combination capsule with BPC-157 serves the gut-focused one.
| Compound | KPV |
| Content | 15 mg, pre-filled |
| Sequence | Lys-Pro-Val |
| Derived from | Alpha-MSH C-terminus |
| Purity | ≥ 99% (HPLC) |
| Evidence base | Animal inflammation models |
| Category | Research use only |
Gut-focused work usually reaches for the capsule combination instead, both routes are stocked.
Before the KPV 15 mg peptide pen reaches the bench
A robust little sequence; the standard rules more than suffice.
What the animal work shows, and what it can’t
A short, honest ledger of what a three-residue sequence has and has not proven.
The KPV file is almost entirely preclinical, and it is fairer to open the pen knowing that. Rodent and cell-culture work has repeatedly shown the Lys-Pro-Val tripeptide dampening inflammatory signalling in gut and skin tissue, often at strikingly low quantities, which is what keeps a fifteen-milligram fragment in serious catalogues. What the record does not hold is one controlled human trial, so any leap from a mouse colitis model to another system stays a hypothesis the literature has simply not tested yet.
The clean part of that record is mechanistic: the fragment keeps the anti-inflammatory arm of alpha-MSH while dropping its pigmentation activity, and that selectivity reproduces well. Everything beyond it, systemic effect sizes, human outcomes, any comparison with licensed anti-inflammatories, sits outside the evidence. Anyone who decides to buy KPV peptide should treat the pen as apparatus for a preclinical question rather than a settled intervention, and lean on the KPV compound page for precisely where that boundary runs.
Reading this batch, line by line
The certificate only helps if you know which two lines to read.
A certificate of analysis is only useful if you can read it, so here is the KPV version. Two lines carry the weight. The HPLC purity figure should sit at or above ninety-nine percent, meaning the trace shows one dominant peak and little beside it. The identity line comes from mass spectrometry: for a Lys-Pro-Val tripeptide the found mass must match the predicted mass of that exact three-residue sequence. A sequence this short leaves almost nowhere for an impurity to hide.
What ties the document to the object is the batch code on the pen itself, and the COA page explains why that heading carries so much weight. It has to match the lot named at the head of the certificate you received; when the two disagree, the paperwork belongs to different material and the check has failed. For even a low-profile compound this closes a real loop: a documented lot ties a later result back to one cartridge. Log it beside your data and request the COA for that specific lot before anything ships.
Its other formats and friends
The gut-route capsule it shares with BPC-157, and the neighbouring tripeptide.
The science behind KPV
The fragment, the parent, and the shelf.
Questions about the KPV 15 mg peptide pen
The KPV three.